Ovarian Cancer News Feed

Ovarian Cancer Drugs Market Latest Industry Scenario, Trends, Share & Future Forecast By 2022
Ovarian Cancer Drugs Market Latest Industry Scenario, Trends, Share & Future Forecast By 2022May 24, 2018 (Heraldkeeper via COMTEX) -- New York, May 24, 2018: The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report ...read more
Source: MarketWatch
Published on Thu, 24 May 2018 10:45:00 GMT
How the Threat of Ovarian Cancer Motivated Me to Surf Big Waves
How the Threat of Ovarian Cancer Motivated Me to Surf Big WavesAll I knew — lying face down on my bedroom floor in a pool of my own snot and tears — was that this was my bottom and everything had to change. I was sick, constantly feeling that nondescript “crappy” feeling. I was broke. I was going through a ...read more
Source: The Inertia
Published on Thu, 24 May 2018 10:40:00 GMT
New options now available for ovarian cancer
New options now available for ovarian cancerOvarian cancer is estimated to affect more than 22,000 women each year and is the fifth leading cause of cancer deaths among women, according to American Cancer Society. Unlike other gynecologic cancers, there are no screening tests for ovarian cancer.read more
Source: Albuquerque Journal
Published on Mon, 21 May 2018 23:27:00 GMT
Talc Ovarian Cancer Class Action OK’d in Canada, U.S. Lawsuits Continue
Talc Ovarian Cancer Class Action OK’d in Canada, U.S. Lawsuits ContinueA Canadian class action lawsuit against pharmaceutical giant Johnson & Johnson has been given the go ahead to proceed. Meanwhile, talcum powder lawsuits continue in the U.S. The class action in Canada involves patients who say they were injured by Johnson ...read more
Source: drugwatch.com
Published on Tue, 22 May 2018 08:14:00 GMT
Heated chemo is the key as Tampa General doctor tackles ovarian cancer
Heated chemo is the key as Tampa General doctor tackles ovarian cancerOver the span of three weeks, Brenda Gotlen watched as her abdomen got bigger. Her lower stomach felt bloated. "It got to the point that I looked nine months pregnant," said Gotlen, a 62-year-old Seffner resident. She made an appointment to see her primary ...read more
Source: Tampa Bay Times
Published on Tue, 15 May 2018 05:26:00 GMT
How to preserve fertility, even after ovarian cancer
How to preserve fertility, even after ovarian cancerNot only are they told they have ovarian cancer, but the treatment that will save their life will kill their hope of having kids. But there are now options for women with cancer. More than 22,000 women in the U.S. will be diagnosed with ovarian cancer, and ...read more
Source: WNDU
Published on Thu, 17 May 2018 13:01:00 GMT
Study examines treatment options for women with recurrent ovarian cancer
Study examines treatment options for women with recurrent ovarian cancerIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) and mucinous epithelium that pseudo-stratifies (left - diagnostic of a LMP tumour).read more
Source: Medical Xpress
Published on Tue, 22 May 2018 23:02:00 GMT
Splash Pharmaceuticals Announces Dose Escalation in Phase I Clinical Trial in Platinum-resistant Ovarian Cancer Patients
Splash Pharmaceuticals Announces Dose Escalation in Phase I Clinical Trial in Platinum-resistant Ovarian Cancer PatientsSAN DIEGO--(BUSINESS WIRE)--May 24, 2018--Splash Pharmaceuticals, Inc. (“Splash”), a closely held private biopharmaceutical company that develops novel cancer therapies, announced the successful completion of the first safety cohort of patients and ...read more
Source: Odessa American
Published on Thu, 24 May 2018 01:02:00 GMT
Machine learning finds rate of change—not value of ovarian cancer biomarker—indicates recurrence
Machine learning finds rate of change—not value of ovarian cancer biomarker—indicates recurrenceResearchers utilized a machine learning algorithm to determine that a higher rate of change—rather than actual value of cancer antigen 125 (CA125)—is associated with abdominal recurrence of ovarian cancer. Findings may help identify patients most ...read more
Source: Health Imaging
Published on Tue, 22 May 2018 11:56:00 GMT
Ovarian cancer: Hard to detect and no screening test
Ovarian cancer: Hard to detect and no screening testOvarian cancer is estimated to affect more than 22,000 women each year in the United States and is the fifth leading cause of cancer deaths among women, according to American Cancer Society. Unlike other gynaecologic cancers, there are no screening tests ...read more
Source: Star2
Published on Thu, 24 May 2018 15:10:14 GMT